This inventor holds 2 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Ptc Therapeutics Mp, Inc., Virginia Commonwealth University. Active years: 2026.
Company Filing History:
2 out of 3 
2 out of 418 
Years Active: 2026
Title: Christopher Rabender: Innovator in Medical Treatments
Introduction
Christopher Rabender is a notable inventor based in Chesterfield, VA (US). He has made significant contributions to the field of medical treatments, particularly in addressing critical health issues such as COVID-19 and radiation exposure. With a total of 2 patents, Rabender's work showcases his commitment to advancing healthcare solutions.
Latest Patents
Rabender's latest patents include innovative methods for treating COVID-19 with sepiapterin. This invention features methods of treating a SARS-CoV-2 infection in a subject, comprising administering an effective amount of sepiapterin or a pharmaceutically acceptable salt thereof. Additionally, he has developed methods for using sepiapterin and its metabolites to treat radiation exposure. This invention provides methods for treating radiation exposure in a subject by administering sepiapterin, tetrahydrobiopterin, or dihydrobiopterin.
Career Highlights
Throughout his career, Rabender has worked with esteemed organizations such as Virginia Commonwealth University and PTC Therapeutics, Inc. His experience in these institutions has allowed him to collaborate with other professionals and contribute to groundbreaking research in the medical field.
Collaborations
Some of his notable coworkers include Eleonora Mezzaroma and Vasily Yakovlev. Their collaborative efforts have further enhanced the impact of Rabender's inventions and research.
Conclusion
Christopher Rabender stands out as an innovative inventor dedicated to improving medical treatments. His patents reflect his expertise and commitment to addressing pressing health challenges.